Chris Hurff

Chris Hurff is an experienced leader in oncology business development and marketing with a strong background in negotiating and closing strategic transactions. At Takeda Oncology, roles included Head of Oncology Business Development and Senior Director of Business Development, focusing on oncology and immuno-oncology deals, including collaborations and antibody drug conjugate platforms. Additional responsibilities encompassed establishing brand strategy and launching oral oncology assets. Previous experience at Millennium Pharmaceuticals involved leading marketing efforts for VELCADE, achieving significant revenue targets, while earlier roles at Corixa Corporation and Chiron Corporation included launching novel therapies and managing oncology marketing teams. Chris holds a Bachelor of Arts in Biology and Environmental Sciences from Dartmouth College and an MBA in Marketing and Health Care from The Wharton School.